InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,426.40
(
0.12%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.83
(
0.05%
)
Bitcoin
65,028.57
(
-0.17%
)
Post# of 704019
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Bearmove

Send PM Follow Ignore
Followers 165
Posts 17686
Boards Moderated 0
Alias Born 01/06/2003

Bearmove

Re: None

Thursday, 04/05/2007 9:35:04 AM

Thursday, April 05, 2007 9:35:04 AM

Post# of 704019
DOW JONES NEWSWIRES

Possis Medical Inc. (POSS) received Food and Drug Administration approval for its AngioJet Spiroflex VG rapid exchange catheter for blood clot removal in coronary conduits.

The Minneapolis medical device manufacturer said the approval allows the device to be marketed for use in saphenous vein bypass grafts in the heart and larger native coronary vessels.

The Spiroflex VG catheter was introduced in July for removing blood clots in larger peripheral arteries.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up